Cell Based Assay Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2
Global Cell Based Assay Market is estimated to value over USD 17.8 billion by 2026 end and register a CAGR of over 7% during the forecast period 2019 to 2026. The Global Cell Based Assay Market is primarily driven by an increase in funding assigned for research and development, growing preference for cell-based assays and an increase in the drug discovery activities. Furthermore, the adoption of high-output screening methods boosts the market growth. Nonetheless, high instrument costs and restrictions on the usage of reagents are factors that can significantly impede the market growth. Furthermore, a lack of skilled labour can restrict the market growth. The inception of innovative technologies like 3D cell-based assays, growing requirement for toxicity screening, advanced detection technologies and broadened cell-based assay applications are projected to provide new opportunities for the market to expand globally. Consumable Segment is Predicted to Stimulate the Market Growth Over the Forecast Period The consumable segment holds the majority of market share in 2019 and is projected to thrive with the highest CAGR value over the forecast period. This growth can be credited to the growing drug discovery activities, especially in emerging economies. The drug discovery segment is predicted to boost market growth over the forecast period. This growth is due to the increase in investments on research and development by pharmaceutical companies. Furthermore, the increasing prevalence of diabetes and cardiovascular diseases is spurring market growth. Moreover, a rapid rise in the drugs used for treating chronic diseases across the world has boosted the market growth. North America currently dominates the market. However, the Asia Pacific region is predicted to grow at a high CAGR value over the forecast period. The growth in this region is largely due to advancements in infrastructure development and massive investments in research and development by governments of emerging economies. Key market players include Thermo Fisher Scientific Inc., Danaher Corp., Becton, Dickinson and Company, GE Healthcare, Merck KGaA, Lonza Group Ltd., Perkinelmer Inc., Charles River Laboratories Inc., Cell Signalling Technology Inc., Promega Corp., Cisbio and Cell Biolabs Inc. Thermo Fisheru2019s BacMam-enabled Cellular Assays technology is used for mammalian cell line transduction which include stem cells and primary cells. It is an efficient and robust method for investigating specific signal transduction events with a customised cell background. Thermo Fisher acquired approximately 57% of its total revenue from China and US combined. The company invests around 4% if its total revenue in research and development to lead the competition in this market. Danaher, in 2019, announced ClearLLAb 10C System for flow cytometry labs. It includes the initial 10-colour CE-IVD immunophenotyping reagent panels for myeloid as well as lymphoid lineages. These tubes use the DURA innovations dry reagents technology for panels that require no refrigeration. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3366&page=requestsample Global Cell Based Assay Market Segmentation: By Product & Services u2022 Consumables u2022 Reagents u2022 Assay Kits o Reporter Gene Assays o Second Messenger Assays o Cell Growth Assays o Cell Death Assays o Other Assay Kits u2022 Probes & Labels u2022 Microplates u2022 Cell Lines o Immortalized Cell Lines o Primary Cell Lines o Stem Cell Lines u2022 Instruments u2022 Services By Application u2022 Drug Discovery u2022 Toxicity Studies o Pharmacokinetic Studies o Pharmacodynamic Studies u2022 Basic Research u2022 Other Applications By End User u2022 Pharmaceutical & Biotechnology Companies u2022 Academic & Government Institutes u2022 Contract Research Organizations By Region u2022 North America u2022 Europe u2022 Asia Pacific u2022 Rest of the World FutureWise Key Takeaways: u2022 Growth prospects u2022 SWOT analysis u2022 Key trends u2022 Key data-points affecting market growth Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3366&page=askfordiscount Competitive Landscape: u2022 Tier 1 players- established companies in the market with a major market share u2022 Tier 2 players u2022 Emerging players which are growing rapidly u2022 New Entrants Objectives of the Study: u2022 To provide with an exhaustive analysis on the cell-based assay market by product & services, by application, by end user and by region u2022 To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) u2022 To evaluate and forecast micro-markets and the overall market u2022 To predict the market size, in key regions (along with countries)u2014 North America, Asia Pacific, Europe and rest of the world u2022 To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions u2022 Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.2.1 Markets Covered 1.2.2 Years Considered for the Study 1.3 Currency 1.4 Limitations 1.5 Stakeholders 2 Research Methodology 2.1 Secondary Data 2.1.1 Key Data From Secondary Sources 2.2 Primary Data 2.2.1 Key Data From Primary Sources 2.3 Market Size Estimation 2.3.1 Bottom-Up Approach 2.3.2 Top-Down Approach 2.4 Market Breakdown and Data Triangulation 2.5 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Cell-Based Assays: Market Overview 4.2 Cell-Based Assays Market, By Product & Service and Application (2018) 4.3 Geographical Snapshot of the Cell-Based Assays Market 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.2 Restraint 5.2.3 Opportunities 6 Cell-Based Assays Market, By Product & Service 6.1 Introduction 6.2 Consumables 6.2.1 Reagents 6.2.2 Assay Kits 6.2.2.1 Reporter Gene Assays 6.2.2.2 Second Messenger Assays 6.2.2.3 Cell Growth Assays 6.2.2.4 Cell Death Assays 6.2.2.5 Other Assay Kits 6.2.3 Probes & Labels 6.2.4 Microplates 6.2.5 Cell Lines 6.2.5.1 Immortalized Cell Lines 6.2.5.2 Primary Cell Lines 6.2.5.3 Stem Cell Lines 6.3 Instruments 6.4 Services 7 Cell-Based Assays Market, By Application 7.1 Introduction 7.2 Drug Discovery 7.2.1 Toxicity Studies 7.2.2 Pharmacokinetic Studies 7.2.3 Pharmacodynamic Studies 7.3 Basic Research 7.4 Other Applications 8 Cell-Based Assays Market, By End User 8.1 Introduction 8.2 Pharmaceutical & Biotechnology Companies 8.3 Academic & Government Institutes 8.4 Contract Research Organizations 9 Cell-Based Assays Market, By Region 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.3 Europe 9.3.1 UK 9.3.2 Germany 9.3.3 France 9.3.4 Rest of Europe 9.4 Asia Pacific 9.4.1 China 9.4.2 Japan 9.4.3 India 9.4.4 Rest of Asia Pacific 9.5 Rest of the World 10 Competitive Landscape 10.1 Overview 10.2 Market Ranking Analysis, 2018 10.3 Key Strategies 10.4 Competitive Leadership Mapping (2018) 10.5 Visionary Leaders 10.6 Innovators 10.6.1 Dynamic Differentiators 10.6.2 Emerging Companies 10.7 Competitive Leadership Mapping for Start-Ups (2018) 10.7.1 Progressive Companies 10.7.2 Starting Blocks 10.7.3 Responsive Companies 10.7.4 Dynamic Companies 11 Company Profiles (Business Overview, Products Offered, Recent Developments, SWOT Analysis, FutureWise Key Insights)* 11.1 Thermo Fisher Scientific Inc. 11.2 Danaher Corporation 11.3 Becton, Dickinson and Company 11.4 Ge Healthcare 11.5 Merck KGaA 11.6 Lonza Group Ltd. 11.7 Perkinelmer, Inc. 11.8 Charles River Laboratories, Inc. 11.9 Cell Signaling Technology, Inc. 11.10 Promega Corporation 11.11 Cisbio 11.12 Cell Biolabs, Inc. 12.. Assumptions and Acronyms 13. Research Methodology 14. List of Sources of Information (Primary and Secondary) Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry u2013 a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: 44 141 628 9353 / 1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
117 views • 10 slides
